Algorithms based on managed care pharmacy data can efficiently identify persons at risk for undiagnosed chronic obstructive pulmonary disease.
Douglas W. Mapel, MD, MPH
Advertisement
Articles by Douglas W. Mapel, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Special Report: The Oncology Care Model, 10 Years Later
2
Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD
3
Long-Term Extension Data Support Durable Benefit of Rilzabrutinib in Persistent, Chronic ITP: David Kuter, MD, DPhil
4
Patients on GLP-1s Increasingly Carry Diagnoses for New Indications
5